Matthew Harrison
Stock Analyst at Morgan Stanley
(3.44)
# 963
Out of 5,139 analysts
708
Total ratings
49.88%
Success rate
3.98%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Maintains: Overweight | $151 → $150 | $124.91 | +20.09% | 44 | Jan 13, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Equal-Weight | $767 → $768 | $733.04 | +4.77% | 58 | Dec 12, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $30 → $28 | $41.83 | -33.06% | 27 | Dec 12, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $83 → $50 | $22.14 | +125.84% | 14 | Dec 12, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $149 → $156 | $164.42 | -5.12% | 56 | Dec 12, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $1,070 → $1,110 | $800.01 | +38.75% | 27 | Dec 4, 2025 | |
| PHVS Pharvaris | Maintains: Overweight | $37 → $41 | $25.09 | +63.41% | 16 | Dec 4, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Equal-Weight | $8 → $4 | $2.96 | +35.14% | 5 | Nov 12, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $104 → $98 | $54.59 | +79.52% | 23 | Oct 28, 2025 | |
| DNLI Denali Therapeutics | Maintains: Overweight | $33 → $30 | $17.99 | +66.76% | 13 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $112 → $126 | $161.42 | -21.94% | 19 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $4 | $0.50 | +696.65% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $460 → $439 | $441.36 | -0.53% | 41 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $20 | $21.13 | -5.35% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Positive | $215 | $190.74 | +12.72% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $3.40 | +76.47% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $0.73 | +585.40% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $35.65 | +57.08% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $27.82 | +97.70% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.84 | +63.04% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $22.20 | -50.45% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.03 | +244.83% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $32.25 | -0.78% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.98 | +377.39% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $2.45 | -59.18% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $19.44 | -48.56% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $10.14 | -21.10% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $33.54 | +31.21% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $4.58 | +183.84% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $23.76 | +236.70% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $6.36 | +843.40% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $109.00 | +98.17% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $3.62 | +38.12% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.96 | +155.10% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $214.35 | -15.09% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $27.15 | -66.85% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $330.41 | -14.65% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $359.27 | -41.55% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $25.65 | +102.73% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $218.66 | -20.88% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $22.49 | +433.57% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $13.14 | +1,026.33% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $108.83 | -24.65% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $55.26 | +19.44% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $4.56 | +755.26% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $39.55 | +16.31% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $8.76 | +299.54% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $1,038.40 | -73.52% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.99 | +535.45% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $13.62 | +355.21% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $18.02 | -4.27% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $106.21 | -21.85% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $62.58 | -84.02% | 4 | Sep 10, 2018 |
Gilead Sciences
Jan 13, 2026
Maintains: Overweight
Price Target: $151 → $150
Current: $124.91
Upside: +20.09%
Regeneron Pharmaceuticals
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $767 → $768
Current: $733.04
Upside: +4.77%
Moderna
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $30 → $28
Current: $41.83
Upside: -33.06%
Legend Biotech
Dec 12, 2025
Maintains: Overweight
Price Target: $83 → $50
Current: $22.14
Upside: +125.84%
Biogen
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $149 → $156
Current: $164.42
Upside: -5.12%
argenx SE
Dec 4, 2025
Maintains: Overweight
Price Target: $1,070 → $1,110
Current: $800.01
Upside: +38.75%
Pharvaris
Dec 4, 2025
Maintains: Overweight
Price Target: $37 → $41
Current: $25.09
Upside: +63.41%
Zentalis Pharmaceuticals
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $8 → $4
Current: $2.96
Upside: +35.14%
BioMarin Pharmaceutical
Oct 28, 2025
Maintains: Overweight
Price Target: $104 → $98
Current: $54.59
Upside: +79.52%
Denali Therapeutics
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $17.99
Upside: +66.76%
Aug 13, 2025
Downgrades: Equal-Weight
Price Target: $112 → $126
Current: $161.42
Upside: -21.94%
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.50
Upside: +696.65%
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $441.36
Upside: -0.53%
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $21.13
Upside: -5.35%
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $190.74
Upside: +12.72%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.40
Upside: +76.47%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.73
Upside: +585.40%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $35.65
Upside: +57.08%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $27.82
Upside: +97.70%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.84
Upside: +63.04%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $22.20
Upside: -50.45%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.03
Upside: +244.83%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $32.25
Upside: -0.78%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.98
Upside: +377.39%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $2.45
Upside: -59.18%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $19.44
Upside: -48.56%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $10.14
Upside: -21.10%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $33.54
Upside: +31.21%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $4.58
Upside: +183.84%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $23.76
Upside: +236.70%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $6.36
Upside: +843.40%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $109.00
Upside: +98.17%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.62
Upside: +38.12%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.96
Upside: +155.10%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $214.35
Upside: -15.09%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $27.15
Upside: -66.85%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $330.41
Upside: -14.65%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $359.27
Upside: -41.55%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $25.65
Upside: +102.73%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $218.66
Upside: -20.88%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $22.49
Upside: +433.57%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $13.14
Upside: +1,026.33%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $108.83
Upside: -24.65%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $55.26
Upside: +19.44%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $4.56
Upside: +755.26%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $39.55
Upside: +16.31%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $8.76
Upside: +299.54%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $1,038.40
Upside: -73.52%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.99
Upside: +535.45%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $13.62
Upside: +355.21%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $18.02
Upside: -4.27%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $106.21
Upside: -21.85%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $62.58
Upside: -84.02%